Heron Therapeutics (HRTX) to Offer $200M in Common Stock
Heron Therapeutics, Inc. (NASDAQ: HRTX) announced an underwritten public offering of approximately $200 million of shares of its common stock ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
